Reinier M. van Hest at University of Amsterdam - Research Interests, Publications & Academic Profile

Reinier M. van Hest

University of Amsterdam

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

40%

Pharmacology

20%

Antibiotic Therapy

60%

Pharmacokinetic

30%

Drug Formulation

20%

Pharmacoepidemiology

20%

Drug Utilization

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

The Dutch list of essential drugs for undergraduate medical education: A modified Delphi study

Article Link

Year:

2023

Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study

Article Link

Year:

2023

An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round

Article Link

Year:

2023

On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives

Article Link

Year:

2023

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

Article Link

Year:

2022

Persistent Borrelia burgdorferi <i>Sensu Lato</i> Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models.

Article Link

Year:

2022

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.

Article Link

Year:

2022

Detecting inappropriate total duration of antimicrobial therapy using semi-automated surveillance.

Article Link

Year:

2022

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma.

Article Link

Year:

2022

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma

Article Link

Year:

2022

Collaborators3

Roger J M Brüggemann

Radboud University Medical Center

NETHERLANDS

Eveline van Poelgeest

NETHERLANDS

Catherijne A J Knibbe

Leiden University

NETHERLANDS

How do Chinese students reach out?

Meet Kite AI